SYGNIS has one project in a phase II efficacy clinical trial. In addition, SYGNIS has several projects in preclinical development and late discovery. Our continuously evolving pipeline focuses on CNS disorders of high unmet medical need such as stroke or cognitive deficits.
* data packages available; continuation of programs depending on additional resources/ partnership